medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

1

Emergence of mcr-9.1 in ESBL-producing Clinical Enterobacteriaceae in Pretoria,

2

South Africa: Global Evolutionary Phylogenomics, Resistome and Mobilome.

3

John Osei Sekyere1#, Nontuthuko E. Maningi1, Lesedi Modipane1, Nontombi Marylucy

4

Mbelle1, 2
1

5
6
7

0084 Prinshof, Pretoria, South Africa.
2

National Health Laboratory Services, Tshwane Academic Division, Department of Medical

8
9
10

Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria,

Microbiology, University of Pretoria, 0084 Prinshof, Pretoria, South Africa.
#

Direct correspondence to John Osei Sekyere, PhD. Department of Medical Microbiology,
University of Pretoria. Email: jod14139@gmail.com; u18392467@tuks.co.za

11
12

Running head: Pathogenomics of mcr-9.1- and ESBL-positive Enterobacteriaceae.

13
14
15
16
17
18
19
20
21
22
23
24
25

1
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

26

Abstract

27

Background. Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are

28

critical-priority pathogens that cause substantial fatalities. With the emergence of mobile mcr

29

genes mediating resistance to colistin in Enterobacteriaceae, clinicians are now left with little

30

therapeutic options.

31

Methods. Eleven clinical Enterobacteriaceae strains with resistance to cephems and/or

32

colistin were genomically analysed to determine their resistome, mobilome, and evolutionary

33

relationship to global strains. The global phylogenomics of mcr-9.1-bearing genomes were

34

further analysed.

35

Results & conclusion. Ten isolates were ESBL positive. The isolates were multidrug-

36

resistant and phylogenetically related to global clones, but distant from local strains. Multiple

37

resistance genes, including blaCTX-M-15 blaTEM-1 and mcr-9.1 were found in single isolates;

38

ISEc9, IS19, and Tn3 transposons bracketed blaCTX-M-15 and blaTEM-1. Common plasmid types

39

included IncF, IncH and ColRNAI. Genomes bearing mcr-9.1 clustered into six main phyletic

40

groups (A-F), with those of this study belonging to clade B. Enterobacter sp. and Salmonella

41

sp. are the main hosts of mcr-9.1 globally, albeit diverse promiscuous plasmids disseminate

42

mcr-9.1 across different bacterial species. Emergence of mcr-9.1 in ESBL-producing

43

Enterobacteriaceae in South Africa is worrying due to the restricted therapeutic options.

44

Intensive One Health molecular surveillance might discover other mcr alleles and inform

45

infection management and antibiotic choices.

46

Keywords: ESBLs; Enterobacteriaceae; mcr-9.1; South Africa; critical pathogens; colistin

47

resistance

48

Introduction

49

Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) are categorised as

50

critical priority 1 pathogens requiring urgent attention with regards to the development of

2

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

51

new antimicrobials 1. Owing to the fatalities caused by ESBL-positive Enterobacteriaceae,

52

carbapenems were introduced as last-resort antibiotics into clinical practice, which

53

unfortunately led to the proliferation of strains expressing carbapenem resistance through

54

ESBLs/AmpCs hyper-expression, porin downregulation and carbapenemase production 2–4.

55

Subsequently, colistin was re-introduced into clinical medicine as a last-resort agent to

56

manage infections resistant to carbapenems, other β-lactams and other antibiotics 5,6.

57

Inexorably, the increased use of colistin also resulted in the emergence of colistin resistance

58

3,5,7,8

59

dissemination of colistin resistance worldwide 5,9,10. Several alleles of the mcr-1 gene such as

60

mcr-1 to mcr-9, have been also been discovered, mainly in Europe and China in several

61

Enterobacteriaceae species including Escherichia coli, Enterobacter spp. Klebsiella spp.,

62

Salmonella spp., etc. 11–14.

63

Worryingly, increasing reports of isolates co-harbouring carbapenemases, ESBLs and mcr

64

genes are being reported worldwide and on self-transmissible plasmids 4,15–19. Such strains

65

could be pandrug resistant, restricting therapeutic options for clinicians and threatening

66

public health 6,8.

67

In this report, we describe for the first time the emergence of mcr-9.1 colistin resistance gene

68

in South Africa and Africa as well as the co-occurrence of mcr-9.1 with ESBLs in

69

Enterobacter hormaechei. We further undertake a global phylogenomic analyses of

70

Citrobacter freundii, Enterobacter hormaechei, Klebsiella variicola, and

71

Providencia/Proteus spp., alongside a global evolutionary analysis of mcr-9.1. These findings

72

call for advanced One Health genomic surveillance to contain such multi-drug resistant

73

strains from further dissemination.

74

Methods

75

Clinical bacterial specimens and antibiotic sensitivity testing

. Since 2016, the discovery of a mobile colistin resistance gene, mcr-1, has enhanced the

3

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

76

An old collection of clinical specimens (n=72) that were obtained in 2013 at a referral

77

laboratory from patients having drug-resistant infections at an academic teaching hospital

78

were analysed 20–22. These patients suffered from several different diseases and the specimens

79

were obtained from different body sites. The specimens were cultured on blood agar

80

overnight and pure colonies were transferred to freshly prepared Mueller-Hinton plates for

81

another 24-hour incubation. The fresh cultures were then used for antimicrobial sensitivity

82

testing and species identification on a MiscroScan Walkaway system. The isolates were

83

further tested for ESBL production using the double-disk synergy testing 23.

84

Enterobacteriaceae species having reduced sensitivity to cephems and colistin were further

85

selected for genomic analyses.

86

Whole-genome sequencing

87

Eleven isolates belonging to Enterobacteriaceae species that are rarely isolated from the

88

referral laboratory were cultured for 24 hours. Their genomic DNA were subsequently

89

isolated using the ZR Fungal/Bacterial DNA Mini-Prep kit (Zymo Research, USA). Briefly,

90

200bp libraries were prepared from the gDNA and size-selected using 2% agarose gel and

91

Pippen prep (Sage Science, Beverly, MA, USA). The libraries were barcoded and pooled

92

together for sequencing on an Ion Proton (ThermoFisher, Waltham, MA, USA). SPAdes

93

assembler was used to assemble the generated raw reads de novo.

94

Bioinformatic and phylogenomic analyses

95

The assembled sequences were deposited at Genbank and annotated with PGAP 24. The

96

resistome of the isolates were determined from the Isolates Browser database of NCBI

97

(https://www.ncbi.nlm.nih.gov/pathogens/isolates#/search/) whilst the mobilome were

98

manually curated from the gff files from Genbank. The isolates’ multi-locus sequence types

99

(MLST) sequence types were identified with the MLST database at CGE

100

(http://cge.cbs.dtu.dk/services/MLST/). INTEGRALL (http://integrall.bio.ua.pt/) was used to

4

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

101

identify the integrons and gene cassettes within the genomes whilst PlasmidFinder

102

(http://cge.cbs.dtu.dk/services/PlasmidFinder/) was used to identify the plasmid replicons.

103

Contigs bearing the mcr9.1 genes were BLASTed (using nucleotide BLAST) to identify

104

genomes with closest nucleotide identity, which were used to draw distance trees using the

105

Fast Minimum Evolution method at a Maximum Sequence Difference of 0.75. The genomes

106

of Citrobacter freundii, Enterobacter hormaechei, Klebsiella variicola, Providencia spp. and

107

Proteus mirabilis were curated from PATRIC (https://www.patricbrc.org) and filtered to

108

remove poor genomes. The filtered genomes were then run through RAxML to draw

109

maximum-likelihood trees that were annotated using Figtree

110

(http://tree.bio.ed.ac.uk/software/figtree/).

111

Results

112

Demographics, genome characteristics & resistance phenome

113

The specimens were mainly sourced from six males and four females, aged between 18 and

114

61, and hospitalized at a single tertiary academic hospital in Pretoria, South Africa (Figure 1;

115

Table 1). Except for the carbapenems, cephalothin, and combinations of clavulanate and

116

tazobactam with cefotaxime/ceftazidime and piperacillin respectively, most of the isolates

117

were resistant to all the β-lactams. Moreover, reduced resistance to piperacillin-tazobactam

118

(in EC009, EC010, and K001) and sensitivity to aztreonam and cefepime (CF004), and

119

cefoxitin (EC015, K001, K006, K130, K063 and PM005) were observed. All the isolates

120

were phenotypically positive for ESBL production, except CF004 (Supplementary Table S1

121

and Table 1). None of the isolates was resistant to amikacin. CF004 was susceptible to all the

122

non-β-lactam antibiotics whilst the remaining strains were resistant to almost all the non-β-

123

lactam antibiotics except tigecycline and Fosfomycin. Four of the isolates were resistant to

124

colistin (Supplementary Table S1).

125

5

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

126

The draft genome sizes of the genomic sequences ranged from 4Mb to 6Mb, with PM005

127

having the lowest GC content (39.2) and coding sequences (3542). The genome coverage

128

ranged from 90X to 102X whilst CRISPR arrays were identified in only two isolates (K001

129

and K063) (Table 1; Supplementary dataset 1).

130
131

The isolates were all multi-drug resistant and agreements as well as discrepancies between

132

the resistance phenotypes (phenomes) and resistance genes (resistomes) were observed

133

(Table S1). In particular, CF003 and CF004 had only blaCMY and aac(6’)-If or fosA7 genes,

134

but expressed multidrug resistance to several antibiotics for which no resistance gene were

135

identified. Such observations were also made with the presence of fosA genes in the isolates

136

and the absence of fosfomycin resistance in almost all the strains as well as the presence of

137

chromosomal AmpCs such as ACT, LEN and CMY, in EC015, K001, K006, K130, K063

138

and PM005, which were all susceptible to cefoxitin (Supplementary Table S1). Notable was

139

the absence of colistin resistance in K006 and K130, which had the mcr-9.1 gene;

140

comparative genomic analyses showed that the colistin-susceptible and -resistant strains

141

shared the same chromosomal mutations in mgrB and pmrB (Table 2). The absence of

142

carbapenem resistance was corroborated by the absence of any carbapenemase gene whilst

143

the ESBL-positive phenotypes agreed with the ESBL genes identified in the genomes

144

(Supplementary Table S1 and Figure 2).

145

Resistome, mobilome and evolutionary epidemiology of mcr-9

146

CF003 and CF004 had the least number of resistance genes, with no ESBL genes. Dominant

147

ESBLs in the other nine isolates included CTX-M-15, TEM-1, OXA-1, OXA-9 and ACT

148

(Supplementary Table S1; Supplementary dataset 1). The genetic environment of the contigs

149

on which the AmpC genes such as blaCMY, blaACT, blaLEN and blaLAP were located strongly

150

suggested their presence on chromosomes. Notably, the blaCMY in PM005 was in close

6

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

151

synteny with ISEc9 (Fig. 2AIII). blaCTX-M-15 and blaTEM-1 ESBLs were almost always found

152

on the same contig, respectively bracketed by ISEc9 and a Tn3 transposon and IS19 and an

153

integrase/recombinase. In particular, aph(6’)-Id:aph(3’’):sul2 resistance genes were

154

commonly found joined to IS19, just after blaTEM-1 in mcr-9-negative E. hormaechei. In

155

PM005, K006 and K130, the genetic environment of blaTEM-1 were different (Fig. 2A). The

156

blaOXA gene was commonly found between catB3 and aac(6’)-Ib on a class 1 integron as gene

157

cassettes or directly on the chromosome, similar to what was observed for blaSHV, blaLEN, and

158

blaACT.(Fig. 2A)

159
160

A recent allele of the mobile colistin resistance gene, mcr-9.1, was identified in three E.

161

hormaechei strains, the first to be discovered from Africa, dating back to 2013. mcr9.1 genes

162

were all found in the immediate environment of a cupin fold metalloprotein, WbuC, similar

163

to blaCTX-M-15 gene. mcr9.1 only occurred once with a blaCTX-M-15 in K063. Nucleotide blast of

164

the contigs viz., K006 contig 131, K063 contig 53 and K130 contig 60, and subsequent

165

phylogenetics using the Fast-Minimum Evolution method showed that the contigs

166

harbouring the mcr9.1 gene were most closely aligned to plasmid genomes from different

167

Enterobacteriaceae species, with a few chromosomes such as that of Enterobacter kobei

168

strain DSM 13645 chromosome being also closely aligned (Fig. 2B). Sequence alignment

169

showed close similarity between the three mcr-9-bearing contigs (Supplemental dataset 2),

170

particularly between the contigs of K006 and K130 (Fig. 2B). Notably, both K006 and K130

171

aligned with very close nucleotide identity with the same genomes, albeit minor differences

172

existed in their nucleotide sequences (Supplemental dataset 2).

173
174

Both K006 and K130 were phylogenetically distant from K063 (Fig. 2B), which is further

175

evinced by the different genomes to which they both most closely aligned with and the

7

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

176

distance of those genomes from each other in the distance trees (Fig. 2B-2C). The

177

evolutionary epidemiology of the mcr-9.1-bearing plasmids or chromosomes is further shown

178

by Fig. 2B-2C, with different plasmid types and chromosomes mediating the spread of this

179

gene within and between species throughout the world. The various mcr-9.1-bearing genomes

180

(plasmids or chromosomes) clustered phylogenetically into six, herein labelled as A-F, with

181

Enterobacter sp. 18A13 plasmid pECC18A13-1 DNA from Japan seeming to be the earliest

182

ancestor and Enterobacter hormaechei strain S13 plasmid pSHV12-1301491 from the USA

183

seeming to be the most recent. All the mcr-9.1 contigs in this study fell within the B

184

phylogenetic cluster, although the genomes that aligned most closely with these contigs

185

changed their phylogenetic clustering between K006/K130 and K063 (Fig. 2B-2C).

186
187

Several integrons bearing gene cassettes of antibiotic resistance genes were identified in

188

various contigs in the isolates (Table 3), with none being detected in the C. freundii strains.

189

PM005 (Providencia alcalifaciens) had a unique integron, In27, whilst K001 (K. variicola)

190

and four E. hormaechei strains harboured In191. K006, K063 and K130, originating from

191

different patients and having the mcr-9.1 gene, harboured the same integrons and very similar

192

gene cassettes. EC009 and Ec010 had the same class 1 integron and gene cassettes and

193

belonged to the same clone (Table 3). Most of the isolates had multiple plasmid replicons,

194

with ColRNAI being the commonest; ColRNAI was also found in the mcr-9.1 strains. The

195

isolates were further grouped using their pMLST (plasmid multi-locus sequence typing).

196

Except for CF004 and PM005, which had no pMLST but contained an A/C2 replicon,

197

IncHI2[ST-1] and IncF subtypes were the main plasmid types. Notably, all the mcr-9.1

198

strains had an IncHI2[ST-1] plasmid whilst two, K006 and K063, co-haboured IncF sub-type

199

plasmids. Although the resistance genes within strains having the same plasmid types were

8

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

200

different, core resistance genes with same genetic environment were present (Fig. 2A; Table

201

4).

202

Phylogenomics

203

The C. freundii strains were not related to any South African or African strain, but to

204

American and European strains. CF004 and CF003 were not related to each other, but CF004

205

was of the same clone as C. freundii CF_12_ST_92 [aac(3)-IIa, aac(6')-Ib4, aadA1, aph(6)-

206

Id, arr-2, blaCMY-48, blaOXA, blaVIM-1, catB2, dfrA14, dfrB1, mph(A), qacE, qnrA1

207

sul1] from Spain and of the same clade as strains 705SK3 [blaCMY-75, blaOXA-48] from

208

Switzerland and CF_13_ST_93 [aac(6')-Ib4, aadA1, aph(3'')-Ib, aph(6)-Id, blaCMY-75,

209

blaVIM-1, catB2, dfrA14, dfrB1, qacEΔ1, qnrB10, sul1, sul2] from Spain. CF003 was of the

210

same clade as MGH142 [blaCMY], UMH16 [blaCMY], MGH141 [aadA2, ant(2'')-Ia, aph(3')-

211

II, blaCARB-2, blaCMY, blaKPC-3, ble, catB11, catB3, cmlA1, dfrA19, mph(E), msr(E), qacEΔ1]

212

sul1], and CRE20 [blaCMY]) from USA (Fig. 3).

213
214

The E. hormaechei strains were clustered into three, with the mcr-9.1 strains being very

215

closely related within the same sub-clade; K006 and K063 were of the same clone. Moreover,

216

EC001 and EC015 were of the same clone just as EC009 and EC010 (Fig. 4A). However,

217

EC001 and EC015 were distantly related in the presence of more closely related genomes

218

(Fig. 4B-C). The mcr-9.1-positive strains were of close evolutionary relationship with other

219

E. hormaechei strains from China, UK, USA, and Thailand: EB_P9_L5_03.19 [aac(6')-Ib4,

220

aph(3'')-Ib, aph(6)-Id, blaACT-56, blaIMP-1, blaTEM-1, catA, catA2, dfrA19, fosA

221

mcr-9.1, qacE, qacEdelta1, qnrA1, sul1], 2011WA-NCV [blaACT-56, catA, fosA], 2011WA-

222

SCV [blaACT-56, catA, fosA], 35415 [blaACT-43 catA, fosA, OqxB], WCHEH090020 [blaACT-56,

223

catA, fosA], UBA4405, WCHEH090006 [blaACT-56, catA, fosA], T38-C141 [aph(3'')-Ib,

224

aph(6)-Id, blaACT-17, blaCMY, blaOXA-48, bleO, catA, dfrA14, fosA, mcr-1.1, mcr-3.1, sul2,

9

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

225

tet(A)], UBA6755, S6 [aac(6')-Il, aadA1, aadA2, aph(3'')-Ib, aph(6)-Id, blaACT-27, blaSHV-12,

226

blaTEM-1, blaVIM-1, catA, dfrA1, dfrA12, fosA, mcr-9.1, mph(A), oqxB, qacE, qacEdelta1,

227

qnrA1, sul1], and UBA5648 (Fig. 4A-B).

228
229

The closely related EC009 and EC010 strains were closely related to Chinese and American

230

strains i.e., WCHEH085055 [aac(3)-IId, aadA5, blaACT-41, blaIMP-4, blaTEM-1, catA, catA2,

231

dfrA17, fosA, mph(A), oqxB, qacEΔ1, qnrS1, sul1, tet(D)], UBA7898 and GN04900 [blaACT-

232

41

233

USA, China, Croatia, Spain, and Turkey. For EC001, UBA6646, SMART_488 [aac(6')-Ib-

234

cr5, aph(3'')-Ib, aph(3')-Ia, aph(3')-VIa, aph(6)-Id, blaACT, blaCTX-M-15, blaKPC-2, blaOXA-1,

235

blaTEM-1, catA, catA2, catB3, dfrA14, fosA, oqxB, qnrB19, sul2, tet(A)], SMART_723

236

[aac(3)-II, aac(6')-IIc, aph(3'')-Ib, aph(6)-Id, arr, blaACT-45, blaDHA-7, blaOXA-48, blaSHV-12,

237

blaTEM-1, catA, catA2, dfrA19, ere(A), fosA, mcr-9.1, oqxB, qacE, qnrB4, sul1] and

238

WCHEX090075 [aadA2, ant(2'')-Ia, blaACT, blaNDM-1, blaSHV-12, ble, catA, catA1, dfrA14,

239

fosA, mcr-9, oqxB, qacE, qnrA1, qnrS1, sul1] were of the same clade whilst WCHEH090043

240

[blaACT, catA, fosA, oqxB], UBA1647, SMART_530 [blaACT, blaOXA-48, catA, fosA

241

oqxB, qnrS1], SMART_1112 [aac(6')-Ib4, aac(6')-Im, aadA1, aadA16, aph(2'')-IIa, aph(3'')-

242

Ib, aph(3')-Ia, aph(6)-Id, arr-3, blaACT, blaCTX-M-15, blaTEM-1, blaVIM-1, catA, catA2, dfrA19,

243

dfrA27, fosA, mcr-9.1, oqxB, qacEΔ1, qnrB6, sul1, sul2, tet(A), tet(D)], SMART_562

244

[aac(6')-Ib4, aac(6')-Im, aadA1, aadA16, aph(2'')-IIa, aph(3'')-Ib, aph(3')-Ia, aph(6)-Id, arr-

245

3, blaACT, blaCTX-M-15, blaTEM-1, blaVIM-1, catA, catA2, dfrA19, dfrA27, fosA, mcr-9.1, oqxB,

246

qacEΔ1, qnrB6, sul1, sul2, tet(A), tet(D)] etc. clustered together (Fig. 4).

catA, fosA, OqxB]. EC001 and EC015 were of a close phyletic group with strains from

247
248

The closest evolutionary relative of K001 was a single strain, WUSM_KV_44 [blaLEN-13,

249

fosA, oqxA, oqxB] from the USA (Figure 5) whilst PM005, which was initially identified as

10

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

250

Proteus mirabilis by MicroScan, but later revised by NCBI’s ANI to P. alcalifaciens, was not

251

related to any Providencia sp. genome (Figure 6A-B); however, it was closely related to

252

Proteus mirabilis Pr2921 strain from Uruguay [catA, tet(J)] (Figure 6C).

253

Discussion

254

We herein report on the first emergence of mcr-9.1 in both South Africa and Africa, in three

255

E. hormaechei strains with a rich repertoire of resistomes and mobilomes. The mcr-9.1 strains

256

were collected among clinical Enterobacteriaceae strains during a molecular surveillance

257

procedure to identify ESBL producers in a referral laboratory. It is a worrying observation to

258

have all the strains, sourced from different patients and wards within the same hospital, being

259

multi-drug resistant. Although the resistomes largely reflected the resistance phenotype,

260

resistance to antibiotics were observed without an underlying resistance gene being

261

identified. Specifically, the C. freundii strains expressed resistance to several antibiotics

262

although not more than three resistance genes were found in them. This could suggest the

263

presence of an unknown resistance determinant or the use of active efflux. Furthermore,

264

sensitivity to certain antibiotics such as colistin was not corroborated by the presence of mcr-

265

9.1. Sensitivity to colistin in strains having the mcr gene has been reported previously and

266

chromosomal mutations have been shown to exert a higher resistance MIC than mcr genes

267

3,25–27

268

Only a single strain with the mcr gene was colistin resistant and the identified mutations in

269

mgrB and pmrAB were also found in susceptible strains. Hence, the identified mutations

270

cannot be responsible for colistin resistance. Consequently, other factors identified for

271

colistin resistance or other unknown determinants could be responsible for the observed

272

colistin resistance 3,7,11,28. The three strains bearing the mcr-9.1 gene were closely related, but

273

the contigs bearing the mcr-9.1 genes were not of the same sequence homology

274

(Supplemental data 2), with the mcr-9.1-contigs’ distance trees showing that K006 and K130

.

11

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

275

were closer (Fig. 2B). It is worth noting that K006 and K130 were phylogenetically distant,

276

but their mcr-9.1-contigs’ were of closer nucleotide identity than K006 and K063, which

277

were of the same clone (Fig. 4). This observation, plus the close alignment of the mcr-9.1-

278

contigs’ with plasmid genomes on Genbank (Fig. 2B), strongly suggest that the mcr-9.1 gene

279

could have been horizontally, instead of vertically, acquired.

280
281

The global evolutionary trajectory of the mcr-9 gene and genomes shows six major

282

phylogenetic clades, herein labelled A to F. The strains and plasmids in clade A seem to be

283

the earliest ancestors of this gene with F being the last and most recent. Moreover,

284

Enterobacter spp., particularly E. hormaechei, and Salmonella enterica plasmids are the

285

commonest hosts of the mcr-9 gene (Fig. 2B). This is not surprising as mcr-9.1 was first

286

identified in most Salmonella Typhimurium 25. The diversity of species and plasmids

287

involved in the dissemination of this gene explains its promiscuity and rapid spread around

288

the globe, further corroborating the need to restrict the use of colistin in both veterinary and

289

human medicine 5,29.

290
291

The genetic support of the various resistance genes, particularly blaCTX-M-15, blaTEM-1, blaOXA

292

and mcr-9.1 identified in these isolates are not new. In particular, the co-occurrence of blaCTX-

293

M-15

294

widely reported in both South Africa and worldwide 4,20–22,30,31. Further, the presence of the

295

mcr-9.1 gene on IncHI2 plasmids as well as the presence of a cupin fold metalloprotein, as

296

observed here, are common around mcr-9.1 genes 25. The promiscuity of IncF plasmids and

297

the abundance of integrons, transposons and ISs in the genomes of these strains is worrying

298

as they might mobilise and facilitate the faster dissemination of these multiple resistance

299

genes to other species and clones 4,31,32.

and blaTEM-1 within Tn3 composite transposons, ISEc9 and IS19 on IncF type plasmids is

12

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

300
301

It is interesting to note that not all the closely related strains around the mcr-9.1 strains

302

harboured the mcr gene. Some of the global strains with very close phyletic clustering with

303

the non-mcr-positive strains contained mcr, and in some cases, carbapenemase (blaNDM,

304

blaOXA-48, blaVIM and blaIMP) genes. Such resistome differences between strains belonging to

305

the same clade suggest the gain and loss of resistance plasmids during the evolutionary and

306

epidemiological trajectory. This could be the case for the other E. hormaechei strains that had

307

no mcr gene. The 11 strains included in this study were phylogenetically distant from any

308

strain from South Africa or Africa, but of very close evolutionary distance to international

309

strains, some of which harboured very rich resistomes, including the co-occurrence of

310

carbapenemases and mcr genes. Thus, the possibility of these strains having been imported

311

cannot be ruled out, a situation that warrants constant surveillance and screening of medical

312

tourists, particularly those from carbapenemase- and mcr-endemic areas 6,33.

313
314

Although carbapenemases were not found in these strains as have been reported elsewhere in

315

mcr-positive strains 34–38, the co-occurrence of mcr and ESBL genes is worrying as they

316

restrict therapeutic options. To date, only mcr-1 genes have been reported in South Africa

317

6,27,39,40

318

suggests that other mcr variants could be present in South Africa and Africa, and intensive

319

clinical surveillance is necessary to unearth these and pre-empt further escalation.

, making the emergence of mcr-9.1 in strains as old as 2013 a worrying situation. This

320
321

Acknowledgements: none

322

Funding: none

323

Transparency declaration: authors declare no conflict of interest

13

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

324

Author contributions: JOS designed and supervised the study, undertook all the analyses,

325

bioinformatics, image designs and manuscript write-up; NEM, LM and NMM undertook the

326

laboratory assays; all authors proof-read and agreed to the final version of the manuscript.

327

Ethical considerations. All protocols and consent forms were executed according to the

328

agreed ethical approval terms and conditions. All clinical samples were obtained from a

329

reference laboratory and not directly from patients, who agreed to our using their specimens

330

for this research. The guidelines stated by the Declaration of Helsinki for involving human

331

participants were followed in the study.

332

References

333

1.

World Health Organization. Global Priority List Of Antibiotic-Resistant Bacteria To

334

Guide Research, Discovery, And Development Of New Antibiotics. WHO (World

335

Health Organization, 2017).

336

2.

Sekyere, J. O., Govinden, U. & Essack, S. The Molecular Epidemiology and Genetic

337

Environment of Carbapenemases Detected in Africa. Microb. Drug Resist. 22, 59–68

338

(2016).

339

3.

Osei Sekyere, J., Govinden, U., Bester, L. A. & Essack, S. Y. Colistin and Tigecycline

340

Resistance In Carbapenemase-Producing Gram Negative Bacteria: Emerging

341

Resistance Mechanisms And Detection Methods. J. Appl. Microbiol. 121, 601–617

342

(2016).

343

4.

344
345

Kopotsa, K., Osei Sekyere, J. & Mbelle, N. M. Plasmid Evolution in CarbapenemaseProducing Enterobacteriaceae: A Review. Ann. New Accepted, (2019).

5.

Poirel, L., Jayol, A. & Nordmann, P. Polymyxins: Antibacterial Activity,

346

Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or

347

Chromosomes. Clin. Microbiol. Rev. 30, 557–596 (2017).

348

6.

Osei Sekyere, J. Current State of Resistance to Antibiotics of Last-Resort in South

14

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

349
350

Africa: A Review from a Public Health Perspective. Front. Public Heal. 4, 209 (2016).
7.

Rule, R., Said, M., Mbelle, N. & Osei Sekyere, J. Genome Sequence of a Clinical

351

Salmonella Enteritidis Sequence Type 11 Strain from South Africa. J. Glob.

352

Antimicrob. Resist. (2019). doi:10.1016/j.jgar.2019.09.014

353

8.

354
355

HIV-seropositive patient. BMC Infect. Dis. 19, 806 (2019).
9.

356
357

Rule, R. et al. A rare case of Colistin-resistant Salmonella Enteritidis meningitis in an

Zhi, C., Lv, L., Yu, L.-F., Doi, Y. & Liu, J.-H. Dissemination of the mcr-1 colistin
resistance gene. Lancet. Infect. Dis. 16, 292–293 (2016).

10.

Liu, Y.-Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-

358

1 in animals and human beings in China: a microbiological and molecular biological

359

study. Lancet Infect. Dis. 16, 161–168 (2016).

360

11.

Osei Sekyere, J. & Asante, J. Emerging mechanisms of antimicrobial resistance in

361

bacteria and fungi: advances in the era of genomics. Future Microbiol. 13, 241–262

362

(2018).

363

12.

Aruhomukama, D., Sserwadda, I. & Mboowa, G. Investigating colistin drug resistance:

364

The role of high-throughput sequencing and bioinformatics. F1000Research 8, 150

365

(2019).

366

13.

367
368

Lima, T., Domingues, S. & Da Silva, G. J. Plasmid-Mediated Colistin Resistance in
Salmonella enterica: A Review. Microorganisms 7, (2019).

14.

Carattoli, A. et al. Novel plasmid-mediated colistin resistance mcr-4 gene in

369

Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Euro

370

Surveill. Bull. Eur. sur les Mal. Transm. = Eur. Commun. Dis. Bull. 22, (2017).

371

15.

Brauer, A. et al. Plasmid with Colistin Resistance Gene mcr-1 in Extended-Spectrum-

372

beta-Lactamase-Producing Escherichia coli Strains Isolated from Pig Slurry in Estonia.

373

Antimicrob. Agents Chemother. 60, 6933–6936 (2016).

15

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

374

16.

Bi, Z. Z. Z. Z. et al. Prevalence of the mcr-1 colistin resistance gene in extended-

375

spectrum beta-lactamase-producing Escherichia coli from human faecal samples

376

collected in 2012 in rural villages in Shandong Province, China. Int. J. Antimicrob.

377

Agents 49, 493–497 (2017).

378

17.

Li, A. et al. Complete Sequences of mcr-1-Harboring Plasmids from Extended-

379

Spectrum-?-Lactamase- and Carbapenemase-Producing Enterobacteriaceae.

380

Antimicrob Agents Chemother 60, 4351–4354 (2016).

381

18.

Kong, L.-H. et al. Various sequence types of Escherichia coli co-harboring blaNDM-5

382

and mcr-1 genes from a commercial swine farm in China. Antimicrob. Agents

383

Chemother. 61, (2016).

384

19.

385
386

Yang, Y.-Q. et al. Co-occurrence of mcr-1 and ESBL on a single plasmid in
Salmonella enterica. J. Antimicrob. Chemother. 71, 2336–2338 (2016).

20.

Mbelle, N. et al. Genomic Analysis of Two DrugResistant Clinical Morganella

387

morganii Strains Isolated from UTI Patients in Pretoria, South Africa. Lett. Appl.

388

Microbiol. Accepted, lam.13237 (2019).

389

21.

Mbelle, N. M. et al. The Resistome , Mobilome , Virulome and Phylogenomics of

390

Multidrug-Resistant Escherichia coli Clinical Isolates from Pretoria , South Africa. Sci.

391

Rep. Accepted, 1–43 (2019).

392

22.

Mbelle, N. M. et al. Genomic analysis of a multidrug-resistant clinical Providencia

393

rettgeri (PR002) strain with the novel integron ln1483 and an A/C plasmid replicon.

394

Ann. N. Y. Acad. Sci. Accepted, (2019).

395

23.

Chirindze, L. M. et al. Faecal colonization of E. coli and Klebsiella spp. producing

396

extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican

397

university students. BMC Infect. Dis. 18, 244 (2018).

398

24.

Tatusova, T. et al. NCBI prokaryotic genome annotation pipeline. 44, 6614–6624

16

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

399
400

(2016).
25.

Carroll, L. M. et al. Identification of Novel Mobilized Colistin Resistance Gene mcr-9

401

in a Multidrug-Resistant, Colistin-Susceptible Salmonella enterica Serotype

402

Typhimurium Isolate. MBio 10, e00853-19 (2019).

403

26.

Osei Sekyere, J. Mcr colistin resistance gene: a systematic review of current

404

diagnostics and detection methods. Microbiologyopen e00682 (2018).

405

doi:10.1002/mbo3.682

406

27.

Sephofane, A. K., Mbelle, N. & Osei Sekyere, J. Comparative Evaluation of

407

CHROMagar COL-APSE, MicroScan® Walkaway, ComASPTMColistin, and Colistin

408

MAC Test in Detecting Colistin-resistant Gram- Negative Bacteria. medRxiv

409

December 2, 1–26 (2019).

410

28.

Asante, J. & Osei Sekyere, J. Understanding antimicrobial discovery and resistance

411

from a metagenomic and metatranscriptomic perspective: Advances and applications.

412

Environ. Microbiol. Rep. 1–25 (2019). doi:10.1111/1758-2229.12735

413

29.

Al-Tawfiq, J. A., Laxminarayan, R. & Mendelson, M. How should we respond to the

414

emergence of plasmid-mediated colistin resistance in humans and animals? Int. J.

415

Infect. Dis. 54, 77–84 (2017).

416

30.

Pedersen, T. et al. Spread of Plasmid-Encoded NDM-1 and GES-5 Carbapenemases

417

among Extensively Drug-Resistant and Pandrug-Resistant Clinical Enterobacteriaceae

418

in Durban, South Africa. Antimicrob. Agents Chemother. AAC.02178-17 (2018).

419

doi:10.1128/AAC.02178-17

420

31.

421
422
423

Carattoli, A. Resistance Plasmid Families in Enterobacteriaceae. Antimicrob. Agents
Chemother. 53, 2227–2238 (2009).

32.

Carattoli, A. Plasmids in Gram negatives: Molecular typing of resistance plasmids. Int.
J. Med. Microbiol. 301, 654–658 (2011).

17

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

424

33.

Rossi Goncalves, I. et al. Outbreaks of colistin-resistant and colistin-susceptible KPC-

425

producing Klebsiella pneumoniae in a Brazilian intensive care unit. J. Hosp. Infect. 94,

426

322–329 (2016).

427

34.

428
429

Logue, C. M. et al. Comprehensive resistome analysis reveals the prevalence of NDM
and MCR-1 in Chinese poultry production. Nat. Microbiol. 2, 16260 (2017).

35.

Zheng, B. et al. Discovery and characterization of an escherichia coli ST206 strain

430

producing NDM-5 and MCR-1 from a patient with acute diarrhea. International

431

journal of antimicrobial agents (2017). doi:10.1016/j.ijantimicag.2017.09.005

432

36.

433
434

Zheng, B. et al. Coexistence of MCR-1 and NDM-1 in Clinical Escherichia coli
Isolates. Clin. Infect. Dis. 63, 1393–1395 (2016).

37.

Lai, C.-C., Chuang, Y.-C., Chen, C.-C. & Tang, H.-J. Coexistence of MCR-1 and

435

NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate. Int. J. Antimicrob.

436

Agents 49, 517–518 (2017).

437

38.

Delgado-Blas, J. F., Ovejero, C. M., Abadia Patiño, L. & Gonzalez-Zorn, B.

438

Coexistence of mcr-1 and bla NDM-1 in Escherichia coli from Venezuela. Antimicrob.

439

Agents Chemother. AAC.01319-16 (2016). doi:10.1128/AAC.01319-16

440

39.

Coetzee, J. et al. Emergence of plasmid-mediated colistin resistance (MCR-1) among

441

Escherichia coli isolated from South African patients. S Afr Med J 106, 449–450

442

(2016).

443

40.

Newton-Foot, M., Snyman, Y., Maloba, M. R. B. & Whitelaw, A. C. Plasmid-

444

mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical

445

isolates from the Western Cape region of South Africa. Antimicrob. Resist. Infect.

446

Control 6, 1–7 (2017).

447
448

18

Sample

Accession

Ag Gen

Referral

ES

code

no.

e

der

hospital

BL

CF003

NXKE0000

25

F

Tshwane

+

CF004

NXKF0000

NXIK00000

34

M

NXIL00000

42

M

51

F

NXIM00000 61

M

NXJF00000 18

NXJG0000

M

NXJH0000
0000

gs

(Mb)

C

tRNAs

sequences

235

5.1

51. 120

79

4873

Tshwane

Tshwane

Tshwane

Tshwane

32

F

Tshwane

+

C. freundii

100

4.9

F

Tshwane
Academic

Enterobacter

169

5.0

hormaechei
+

51. 85

Enterobacter

+

Enterobacter

446

4.9

64

4576

Enterobacter

757

5.0

Klebsiella

113

4.9

Enterobacter

4762

55. 107

50. 72

403

6.0

57. 75

73

4620

5.0

hormaechei

56. 79
0

19

0

e (X)

PR

7

99X

0

2508

7

102X

0

1901

8

94X

0

2088

7

95X

0

8

98X

0

6

96X

0

18

90X

1

37

92X

0

27
73

4763

2035
35

56

4604

3441
69

56

5913

0
260

CRIS

80

6

variicola
+

71

1

hormaechei
+

55. 110

2508

L5 Coverag

64

1

hormaechei
+

54. 101

N50

64

9

hormaechei

Academic
27

RNAs

7

Academic

0000

K006

-

Academic

000

K001

Tshwane

Academic

000

EC015

Coding

8

Academic

000

EC010

No. of

Academic

000

EC009

G+ No. of

Academic

0000

EC001

C. freundii

Conti Size

1052
56

68

4824

8612
7

It is made available under a CC-BY-ND 4.0 International license .

0000

Species

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Table 1. Demographic and genomic characteristics of the isolates

NXKO0000

+

0000

K063

NXJN0000

0000

5.1

41

M

Tshwane

+

Academic
29

M

Tshwane
Academic

Enterobacter

Providencia

59

4801

8
223

5.2

hormaechei
+

54. 74

4.0

alcalifaciens

9

90X

0

55

90X

2

8

102X

0

37

55. 102

78

4951

9
96

190,0

6024
0

39. 72

60

3542

2

1939
47

Table 2. Point mutations on the colistin chromosomal resistance genes of the E. hormaechei isolates from South Africa

Isolate ID

EC001
EC009
EC010
EC015
K006
K063
K130
PM005

MIC
<=2
<=2
>4
>4
<=2
>4
<=2
>4

pmrB
pmrA
S175N, T210S, I227L, No mutation
A233T, A344T
T121A, I134V, A344T

Intrinsic resistance

*Reference E. hormaechei genome used was Enterobacter hormaechei strain:C15117 (PRJNA494598)

20

phoP
No mutation

phoQ
No mutation

mgrB
M1V

It is made available under a CC-BY-ND 4.0 International license .

NXKC0000

109

hormaechei

0000

PM005

Enterobacter

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

K130

Integron

Cassette arrays (location on contig)

CF003

None

None

CF004

None

None

EC001 (ST-459)

In191, In705, In363

EC009 (ST-231)

In191

dfrA14b
-attC
dfrA14b
-attC
;
arr3
-attC
-ereA3
-attC
aadA1 -partial
dfrA14b
-attC
arr3
attC
ereA3
attC
aadA1
aadA1ai
-attC
-3'CS; dfrA14b
-attC
dfrA14b
-attC
qacEΔ1
-aacA4
-attC
-arr3
attC
-3'CS
aacA4
-attC
aadA2
-attC
-3'CS;
-attC
-ereA2Δ::IS1247
,aac3
,arr7
aacA27
attC
aadA2
-attC
-3'CS; aacA4
-attC
;
aacA27
-attC
-ereA2D::IS1247
,aac3
,arr7
.
attC
aadA2
-attC
-qacEΔ1-3'CS; aacA4
-attC
.
-attC
-ereA2D,aac3
arr7
-attC
-qacEΔ1aacA27
3'CS
(94-660)

(593-1159)

(581-666)

(587-672)

(1584-2186)

(1578-1691)

(120-1583)

(114-170)

(1-119)

EC010 (ST-231)

In191

(471-1037)

(465-550);

(1584-2186)-

(1578-1691)-

(5378-5463)

(120-1583)-

(114-170)-

(1-119)

EC015

In191, In705

K001 (ST-1791)

In191, In792

(52-907)

(854-913)

(5384-5950)

(53-619)

(540-625);

(1484-1584)

(815-1483)

(814-880)

(212-819)

(206-319)

K006

In46, In127, In615

(2592-3230)

(5380-6117)

(2586-2657);

(80-935)

(74-133)

(5374-5443)

(3446-5116)

(2616-3425)

(2075-2470)

(2589-3398)

(2048-2443)

(74-130)

K130 (ST-90)

In46, In127, In615

(53-908)

(5352-6089)

(47-106)

(5346-5415)

(2566-3204)

(2560-2631)

(3419-5088)

(47-103)

K063

In46, In127, In615

(125-980)

(5425-6162)

21

(119-178)

(5419-5488)

(2638-3276)

(2661-3470),

(2632-2703)

(2120-2515)

(119-175)

It is made available under a CC-BY-ND 4.0 International license .

Sample code (MLST)

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Table 3. Gene cassettes and integrons found in the isolates

dfrA12
qacEΔ1

In27

-attC
-sul1

(5645-6228)

(7513-7860)

-gcuF
-orf5

(6145-6234)

(7854-8693)

-attC
-3'CS

(6229-6548)

-aadA2

(6495-6554)

(6549-7404)

-attC

(7351-7410)

-

(8821-9321)

Table 4. Resistome and mobilome characteristics of the isolates

Species

Resistance genes

Plasmid replicons

pMLST

Integrons

In191

(MLST
Clone)
IncF[F-:A13:B-]

EC009 (ST-

Enterobact

ARR-2:ere(A), aac(3)-IIa, aadA1, strA:strB:sul2, fosA, oqxA:oqxB, sul1:cmlA1, dfrA14, catA2,

IncR, ColpVC,

IncF[F-

231)

er

blaACT-25, catB3:blaOXA-1:aac(6')Ib-cr5, blaTEM-1B:::blaCTX-M-15, blaOXA-9, aph(3'')-Ib,

ColRNAI

:A13:B-]

hormaechei

aph(6)-Id, blaLAP-2, catA,, cmlA5, qacEdelta1, qnrS1

EC010 (ST-

Enterobact

aph(3'')-Ib, aph(6)-Id, aadA1, aac(3)-IIa, QnrS1, QnrB1, fosA, sul1, dfrA14, dfrA1, tet(A), tet(A),

Col(BS512), IncR,

IncF[F-

231)

er

blaACT-41::IS2:QnrS1, sul2::strB:strA:blaTEM-1B:::blaCTX-M-15, blaCMY/LAP-2, aac(6')Ib-

Col(MG828),

:A13:B-]

hormaechei

cr5:blaOXA-1:catB3, oqxA:oqxB, catA, qacEdelta1, tet(A)

ColpVC, ColRNAI

C. freundii

blaCMY-79, aac(6')-If

IncA/C2, ColRNAI

CF003

IncHI2[ST1], IncF[F:A13*:B-]

IncHI2[ST-1]

22

In191

None

It is made available under a CC-BY-ND 4.0 International license .

Sample code

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

PM005

C. freundii

blaCMY-79, aac(6')-If

IncA/C2, ColRNAI

IncHI2[ST-

None

1], IncF[F:A13*:B-]
Enterobact

ARR-2:ere(A), aadA24, aac(3)-IIa, strA:strB:sul2, sul1:cmlA1, QnrS1, fosA, oqxA:oqxB, dfrA14,

459)

er

catB3, blaOXA-1:aac(6')Ib-cr, catA2, blaACT-7, blaOXA-9, blaTEM-1B:::blaCTX-M-15

IncR, ColRNAI

IncHI2[ST-

In191,

1]

In705,

hormaechei

EC015

In363

Enterobact

aadA1, strB, strA, aac(3)-IIa, sul2, fosA, QnrB1, dfrA14, tet(A), catA1, catB3, blaACT-16, blaCTX-M-

er

ColRNAI

IncHI2[ST-

In191,

15, blaOXA-1, blaTEM-1B, aac(6')Ib-cr

1]

In705

Enterobact

aac(3)-II, aac(6')-IIc, aac(6')-Ib3, aadA2, aph(3'')-Ib, aph(3')-Ia, aph(6)-Id, arr, blaACT-56, blaSHV-12, ColRNAI

IncHI2[ST-

In46,

er

blaTEM-1, catA, catA2, dfrA19, ere(A), fosA, mcr-9.1, qacEdelta1, sul1, sul2, tet(D)

1],

In127,

IncF[K1:A-

In615

hormaechei

K006

hormaechei

:B-]

K130 (ST-90) Enterobact

K063

aacA4, aadA2, strA, aph(3')-Ia, aac(6')-IIc, strB, fosA, ere(A), sul1, sul2, tet(D), catA2, blaTEM-1B,

ColRNAI

IncHI2[ST-

In127,

1]

In46, In615

er

blaACT-15, aac(6')Ib-cr, aac(3)-II, aac(6')-Ib3, aph(3'')-Ib, aph(3')-Ia, aph(6)-Id, arr, blaACT-56,

hormaechei

blaSHV-12, catA, dfrA19, mcr-9.1, qacEdelta1

Enterobact

aacA4, aadA2, aac(3)-IIa, aph(3')-Ia, aadA1, sul1, sul2, fosA, ere(A), QnrA1, dfrA12, dfrA19, tet(D),

er

catB3, catA2, blaACT-15, blaTEM-1A, blaCTX-M-15, blaOXA-1, blaOXA-9, aac(6')-IIc, aac(6')-Ib3,

:B-],

hormaechei

aph(3'')-Ib, aph(6)-Id, arr, blaACT-56, blaSHV-12, mcr-9.1, qacEdelta1

IncHI2[ST-

23

IncR, ColRNAI

IncF[K2:A13 In127,
In46, In615

It is made available under a CC-BY-ND 4.0 International license .

EC001 (ST-

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

CF003

IncF[K12:A-:B-]

K001 (ST-

Klebsiella

ARR-3, fosA, sul2, aacA4, strB, strA, QnrB66, oqxB, oqxA, frA14, blaCTX-M-15, blaLEN13, blaTEM-

1791)

variicola

1B, aac(6')Ib-cr

IncR, ColRNAI

IncF[K12:A-

In191,

:B-]

In792

K006

Enterobact

aac(3)-II, aac(6')-IIc, aac(6')-Ib3, aadA2, aph(3'')-Ib, aph(3')-Ia, aph(6)-Id, arr, blaACT-56, blaSHV-12, ColRNAI

IncHI2[ST-

In46,

er

blaTEM-1, catA, catA2, dfrA19, ere(A), fosA, mcr-9.1, qacEdelta1, sul1, sul2, tet(D)

1],

In127,

IncF[K1:A-

In615

hormaechei

:B-]
IncF[K2:A13:B-]

K063

Enterobact

aacA4, aadA2, aac(3)-IIa, aph(3')-Ia, aadA1, sul1, sul2, fosA, ere(A), QnrA1, dfrA12, dfrA19, tet(D),

IncR, ColRNAI

IncF[K2:A13 In127,

er

catB3, catA2, blaACT-15, blaTEM-1A, blaCTX-M-15, blaOXA-1, blaOXA-9, aac(6')-IIc, aac(6')-Ib3,

:B-],

hormaechei

aph(3'')-Ib, aph(6)-Id, arr, blaACT-56, blaSHV-12, mcr-9.1, qacEdelta1

IncHI2[ST-

In46, In615

1]
pMLST not detected

PM005

Providencia

aac(3)-IIa, aadA2, sul2, sul1, dfrA12, tet(J), tet(A), cat, floR, aph(3'')-Ib, aph(6)-Id, blaCMY-2,

alcalifacien

blaSCO-1, blaTEM-131, catA, qacEdelta1

A/C2

None

In27

None

None

None

s

CF004

C. freundii

blaCMY-151, fosA7
24

It is made available under a CC-BY-ND 4.0 International license .

IncF[K1:A-:B-]

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

1]

were hospitalized (B) and their gender (C) are shown herein. These were calculated directly from the source documents populated in Microsoft
Excel.

integrons/recombinases (red arrows) and transposons/ISs (orange arrows) bracketing the resistance genes (green arrows) are shown for the
various isolates under panels I to XI in 2A. The evolutionary distance and relationship between the contigs bearing the mcr-9.1 and highly
similar genomes obtained from Genbank are shown in three different trees labelled A (K006), B (K130) and C (K063) in 2B. The contigs from
this study are labelled red and the genomes of closest alignment are labelled either green (for A|K006 and B|K130) or blue (for C|K063). The
various phyletic groupings that form a separate clade are labelled from A to F under different colours to show the evolutionary trajectory of mcr9.1.
Figure 3. Global phylogenomics of Citrobacter freundii strains obtained from PATRIC/GENBANK. The relationship of the two C. freundii
strains, CF003 and CF004 (shown as blue), to all C. freundii genomes deposited at GenBank and PATRIC were analysed and drawn into two
trees, A and B. Genomes belonging to the same sub-clade with the closest evolutionary distance are coloured as red whilst isolates from South
Africa are shown as green (A). The various phylogenetic clades and sub-clades are highlighted together and uniquely to show their evolution and
epidemiology. The trees were drawn using the maximum-likelihood method in RAxML, using Streptomyces sp. MUSC164 as reference.

25

It is made available under a CC-BY-ND 4.0 International license .

Figure 2. Genetic environment of β-lactamase and mcr-9.1 genes and evolutionary epidemiology of mcr-9.1. The mobile genetic elements viz.,

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Figure 1. Demographic characteristics of patients from whom the specimens were sourced from. The patients’ ages (A), the hospital where they

hormaechei strains, EC001, EC009, EC010, EC015, K006, K063 and K130 (shown as blue), to all E. hormaechei genomes deposited at
GenBank and PATRIC were analysed and drawn into three trees, A, B and C. Genomes belonging to the same sub-clade with the closest
evolutionary distance are coloured as red. The various phylogenetic clades and sub-clades are highlighted together and uniquely to show their

reference.
Figure 5. Global phylogenomics of Klebsiella variicola strains obtained from PATRIC/GENBANK. The relationship of the K. variicola strain,
K001 (shown as blue), to all K. variicola genomes deposited at GenBank and PATRIC were analysed and drawn into two trees, A and B.
Genomes belonging to the same sub-clade with the closest evolutionary distance are coloured as red. The various phylogenetic clades and subclades are highlighted together and uniquely to show their evolution and epidemiology. The trees were drawn using the maximum-likelihood
method in RAxML, using Streptomyces sp. MUSC164 as reference.
Figure 6. Global phylogenomics of Providencia alcalifaciens and Proteus mirabilis strains obtained from PATRIC/GENBANK. The
relationship of the P. alcalifaciens strain, PM005 (shown as blue), to all Providencia (A and B) and Proteus (C) genomes deposited at GenBank
and PATRIC were analysed and drawn into two trees, A, B and C. Genomes belonging to the same sub-clade with the closest evolutionary
distance are coloured as red. The various phylogenetic clades and sub-clades are highlighted together and uniquely to show their evolution and
epidemiology. The trees were drawn using the maximum-likelihood method in RAxML, using Streptomyces sp. MUSC164 as reference.

26

It is made available under a CC-BY-ND 4.0 International license .

evolution and epidemiology. The trees were drawn using the maximum-likelihood method in RAxML, using Streptomyces sp. MUSC164 as

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Figure 4. Global phylogenomics of Enterobacter hormaechei strains obtained from PATRIC/GENBANK. The relationship of the seven E.

2A that can be zoomed to clearly see the plasmids and genomes bearing the mcr-9.1 genes are shown for K006 (A), K063 (B) and K130 (C),
which are coloured or highlighted as yellow.

tested using the MicroScan is shown, with those coloured as green being resistant according to the CLSI breakpoints. Those coloured as blue are
resistant according to the EUCAST breakpoints. Those not coloured are susceptible. The various antibiotic classes to which the antibiotic agents
belong are shown above each antibiotic in unique colours and the resistance genes per isolate are shown in the last column.

Supplemental dataset 1. General data of demographic, phenotypic and genomic results used for this study.
Supplemental dataset 2. Sequences and alignment of contigs harbouring the mcr-9.1 genes.

27

It is made available under a CC-BY-ND 4.0 International license .

Supplemental Table S1. Antimicrobial sensitivity results and resistome of the isolates. The sensitivity of the isolates to the various antibiotics

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Figure S1. The evolutionary epidemiology of mcr-9.1 genes contained on different plasmids and genomes worldwide. A PDF version of Figure

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

cte
roba
Ente
ain

tr
sis s
gen
gfan
xian
bsp.
i su
eche
rma
r ho

sequ
en
com
plete

e
enc

IM
4

eq
ue
nc
e

-V

es

en
qu
se

,p

om

pl
ete

sse
mb
ly

,c

me
a

38
00

no

02

ge

9_
CT
XM

te
C4
5

id
p

iso
la

m

ter
ium

las
8p
03

ac

20

xb

EH
0

om
ple

clo
aca

CH
str
ain

rc

ei

cte

e

rm

ter
o

ae

ba

ch

nc

loa

ca

W

ec

er

ue

ob
act

eq

En
ter

ce

las
mi
d:

pC
45

co
mp
let
M0
81
3,
dp
MR
VI
mi

17
62
6p
las

es

tra

in

Cit
rob
act
er
fre
und
ii

ter
bac
Cit
ro

MR
SN

freu
n

dii

ter f
bac
Citr
o

com
ple
te s
equ
enc
e

stra
in
680
pla
sm
id
p68
0_1
,

reun

stra
i

n5

dii s

65

train

pla

154

sm
id

plas

p56

mid

5_1

, co

p15

mp

4_1

lete

, co

seq
u

mpl

ete

enc

e

sequ

plasm
id pP
1016
164
pP10
ylata
r box
deca
cia a

Lecl
er

NODE_

Klebs
iella p
ne

ome

uence

uence

te seq

136_len

umon
ia

gth_248

strai
n

9_cov_

e sub
sp. pn
eumo
nia

45.3752

e stra

52, who

in H1
1

4- 2,

plasm
id

le geno
me sho
tg

pH11
, com

ce

plete
se

ence
un sequ

genome
e, complete
chromosom
DSM 13645
r kobei strain

omple

complete sequence

te sequence
1491, comple

p le te se q
264, com

1-1, c

Enterobacte

pSHV12-130

I2 -1 5 0 2
id p In c H
6 p la sm

MP, complete sequence

i stra in S

U814

en
lete g

cds

ds

e

s
te

enc

le
mp

equ

co

te s

1,

te c

ple

ple

com

om

kb,

e, c

331

llel

ete
mpl
, co

.1 a

llele

cr-9

e, m

12_
cH
PIn
IM

Enterobacter cloacae plasmid pE
C-I

in S13 plasmid
rmaechei stra

rmaeche

USMD

gen

dp

p
com
E20,

r-9)

a
-9.2
mcr
ne,

mc

r sp.
bacte

.1 (

5_001,
Enterobacter hormaechei strain C45 plasmid pC4

ho
Enterobacter

a c te r h o

id pA

ro
Ente

R-9

MC

ge
r-9)
(mc
9.2

ase

sfer

RMC

tran

ase

plasm

ine

mi

a
ov

UK

12-

ca

ter

En

ho

p
bs

a
ric

ac
ob
er
En
t

n
ae

e

su

om

t
yla

rb
eca

plas

mid

C

1, co

mple

IM
nP

st

ae
oac

amed

nce

2,

i
lasm

p

38

B
rain

equ

is
ndi

enc

e

osp

ph
065

090

ER
CH

feras

W

rain

i st
mpi

10
mcr-

0065

09
HER

ce

f

gene

, comp

te se
omple

ed1, c

am
d unn
i
m
s
a
l

p

OS
AARG

D

rain F

ica st
inolyt

ornith

tella
Raoul

mplet
0065, co

9

id pM
65 plasm

900

rain W
ampii st

roggenk

acter
Enterob

enome

, complete g

complete s

equence

13-1 DNA
id pECC18A

sm

sp. 18A13 pla

Enterobacter

V1015 plasmid pCAV1015

-114, complete sequence

me, complete genome

Buttiauxella sp. 3AFRM03 chromoso

complete genome

Salmonella enterica subsp. enterica serovar Newport strain 0307-213,

mplete sequence

rica

rica subsp. ente

Salmonella ente

Klebsiella

EC62,
pIMP-4-

id
62 plasm

C
e strain E

ca

cter cloa

Enteroba

13-1A_261, co
smid p09-0368

la

9-036813-1A p

berg strain 0
serovar Heidel

Klebsi

train CAV

ella ox

te
erobac

Ent

Lecle

rcia a

decar

me

geno
plete

rom
11 ch

Lecl

904_

sp.
acter

7
NMI

ercia

e, co

osom

ei
aech

Esc

m
chro

i
stra

her

nce

e
te s

-1,

7
W1

lasm

ce
uen

7p

te
ple

rc
ecle

L

com

2,
HI

En

ter

863

N1

e

t
ple

in N

nt

d
mi

20

e
se
ete

ce
en
eq
u
mp

eq
ue
nc

e

let
es
co

e
uen
c

nderup strain 76 plasm

train 64 pla
m var. 5- s
Typhimuri
u
rica serova
r
subsp. ente
a enterica
Salmonell

bsp. enterica serovar Br
ae

d, parti
plasmi
ain 77
2:i:- str
4,[5],1
erovar
nterica
s
ubsp. e
terica s
ella en

Salmon

Salmonella enterica su

smid, partia
l sequence

ence
al sequ

plete
, com
amed
1
d unn
lasmi
174 p
train
er clo
acae
s
obact

Enter

eund
ter f
r
obac
Citr

id, partial sequence

ce
seque
n

lete
s
omp
09, c
47-3
id pR
lasm
47 p
ain R
ii str

lasm
028
p
ECL
14_
UH
ae N
loac
p. c
ubs

cae
s
cloa

eque

seq
ete
mpl
, co
NA
8_1
D
_EC

H14
NU
id p

n1
5-S
A
stra
i
eric
a
ent
sub
sp.
rica
ent
e
lla

nce

uen
ce

seq
mp
8, c
o
010
2
-SA

id p
SE
15
010

la p

neu

mo

28
pla
sm

nia

ae

es

ch

tra
i

ei
s

nN

tra
in

K2

20

9p

71

las

mi

0p
las

dp

mi

K2

dp

9,

IM

lete

P-

com

20

ple

71

0,

te s

co

equ

mp

enc

let

e

es

.1,
20
09
SA
20
dp
mi
las
0p
62
94

00
as
ric
nte

acte
r

ce

erob

uen
seq

pid A

ine--li

anolam

ence

lete sequ

phoeth

r phos

ene fo

cr-9 g

ed, comp

id unnam

Ent

lete

one

ce

mp

, co

e

M1

enc

equ
es

SE
P4-

pIM

let
mp

mid

co
b,
8k

s
pla

nce

que

e se

R48

: CN

nome
te ge

med m

004 plasm

4 unna

. 361154

9_327

_10_R

mid

plas

plet

bly,

com

.13
63

-3,

U1
nM

7-2
97

trai

141

sem

mple

H_WA

str
ftenberg

quence
HI2, complete se

Sal
m

n
ue

34
dp

s
um

p23

e as
enom

Kl

seq

mi

ri
mu

ac
ter
ho
rm

L02

_D
EC
SU
pO
id
m
pl
as
42
PC

CK
M
UV

ell
ae

ce

en

qu

OS

se
e
nc

ue

eq

te

ple

om

phi

mid

48 g

plas

lm
on

ete

ete

ain

es

eq

ue

nc

pl

pl
es

c
6,

las
7p
97
34

Ty

41

CNR

Sa

mp

es

om

m

str

co

ge
ns
is

,
PQ
let

an
gf
an

IM
Cmp
co

xi

pE

let

pM

,c

4,

-29

1
15

p.

co

mp

m

4A

8a

1
AV
pC

su
bs

com

e

co

88

TEN
dp

id

in

ch
ei

3,

S7

mi

sm

pla

a
str

r
ova

231

ae

ce

enc

52

id

seq

equ

45

id

m
s
pla

1
15

ii
alt

rw

ige

ser

rain

late

ho
rm

as

pl
H3

V1
CA

ste

rica

a st
ytic

e iso

ter

ae
NI

ain

sp.
sub

nte
p. e

nol

onia
eum

e, co

_TYP

osom

a HUM

hrom
E5 c

er
ob
ac

ac
EC

str

hei

aec

ubs

ithi

a pn

train

enteric

rovar Sen

1plasmid p52501

se
enterica

En
t

1,

2-m

_0

as

lete

te s

p1

88

ae

ii
ng

rm
ho

s
ca

orn

siell

s
chei

subsp.

a subsp.
a enteric

nterica

e
orma

nella e

ter h
robac

Salmo

ll
Salmone

ndii strain 525011

Cronobacter sakazakii strain GZcsf-1 plasmid pGW1, complete sequence

Citrobacter freu

It is made available under a CC-BY-ND 4.0 International license .

Ente

e

Kl

lla

ch

Es

ie
bs

ri
nte

i
er

qu

Kleb

lla

ch

ulte

i
as

ia

la e

pn

co

Rao

m
eu

nel
mo

li

a
str

er

in

i
on

rsi
ru

CY

N

Sal

ae

b
su

U

act
ob

s

p.

-2

a
qu

cte

3

7
6-

sip

ba

ne

ter
En

n
mo

a
pl

M

pl

nce

ple

T5

let

id

4A

ho

dp

pla

S7

ac
clo

sm

o

um

ter

a
ni

c
ba

t
en

id

pN

yto
Ph

es

al

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

U

CY

i
tra

c
eri

S

6
-2

1

nM

as

a
ell

7
72

ro

t
en

-7

Ec

2p

sm

str

lo

7p

que

pS

C-

A,

23

ain

e se

mp

ph

ch

te
En

p.

1
3-

la

c
eri

s
ub

,c

sm

id

55

ei

P26

PR

T5

04

rc

e
aS

om

qu
en
c

id

p

id p

28

ae

te
ac

a
rov

p1

pla

str

W

rm

plet

se

qu

en

ce

e

eq

ue

nc

e

omplet

te seq

eque

uen

17

EK

ob

rC

t
le

C1

CH

er

mo

es

7

7
72

com

, co

ain

tra

ho

t
En

n

a
ub

u
eq

4
A_

ete s

sm

is

ter

mpl

sm

str

mi

in

78,

-115, c

mple

IM

las

ac

en

77

t
as

be

ob

ce

,c

r. C

ae

l
Sa

om

FS

su

r
nte

ll
ne

p

AN

pla

aec

ko

ter

SA
2

ica

bsp

RJ7

28

En

let

iel

00

.e

ter

q

e
es

ae

pRH

rm

ac

ue

ebs

r
nte

50

s
pla

ho

ain

ob

e
nc

rain

ac

ter

m

o
,c

ero

s
ica

plas

51

clo

En

ob

r
va

a
Inf

ter

seq

ter

nte

e

t
ple

er

d, co

e st

ac

n
ue

sm

la
is p

ob

ce

pR

id

aca

hei

ter

in

t

En

,c

R
H-

er c

u
seq

om

27

tra
es

ca
loa

act

e

las

186

e
nc

46

dp
mi

3p

E

178

02

ob

M, co

li R

clo

seq

En

p.
ia s

ter

4-ND

-b38

, complete

V1335

0780

LEC

-R1

bac

id pCA

id p7

id p

mid

tero

id p

W1

lasm

En

,c
om
pl

Ent

ac
rob

a co

le

p
com

tra

er

ichi

que

horm

act
erob

lasm

H1 p

1099-114

5 plasm

lata p

SNI

me

ete g
l
p
m

n S5

boxy

sp. L

eno

b

Citro

AV133

m
e, co

osom

mid pCAV

train C

chrom

KU_
r sp. D

1099 plas

ytoca s

osome

1
NT_0

rase M

transfe
1, com

CR-9.
DS

plete C

0.02

oxytoca s

sequence

complete

nce

e seque

CHER0

lete seq

uence

e

quenc

c

seque

nce

h

osp
or ph

gg
ter ro

roba

ns
A tra

C

mp
enka

quen

e
amin
anol

hoet

t

bac

ero
Ent

id

--lip

a

enk

gg
er ro

Re MC

nce

uence

sequence

e sequ

ence

lete
omp

,c

10.1

CR10_0

8-MDR

Klebsiella oxytoca strain CA

th
hoe

_431

plete

A tr

ine

rob

HI2

era
ansf

id
--lip

lam
ano

freu

r
acte

1
CR-

se M

dp

o

r
nte

17
OZ

r-1
(mc

0.1

p
com

mc
ne,

e

0) g

ue
seq

lete

ii W

te se

1, com

pOXA436,

r-10

l

rc

te
bac

lle
.1 a

ete
mpl

o

le, c

rai

Ente

d unn

10E

s
pla

t

te s

pD6

E
dp

B

cle

Le

7

C2

ad

a
rci

2
27-

mi

Cit

610

, co

ox

com

ple

te s

t

as

l

en
equ

le
mp

J65

n
rai

E

1, c

ce

ro

e

38-

o

mo

h
6c

n
mo

me

g

le
mp

,c

e
som

ell

nc

o
en

te

.e

c
de

enc

017

me

r
se

ri
nte

equ

002_

p50510

497 plasmid

las

train AMA

9p

r asburiae s

ce
en

Enterobacte

rM

F

in D

pGM

lasmi

plasmid

00

mid

365 p

05108

1_

strain 5

08141

lam

3.1

kazakii

ri

ea

n
ba

str

te
ne

s
ka

da

A
DA

10-

plas

AR_0

u
eq

acter sa

strain

E1

annii

s
te
ple

Cronob

hoffm

dp
mi
las

ubsp.

1p

chei s

ain

C
AT

tr.

R

o

51

C

te s

stra

I14-

rmae

sfer
tran

ano

5_0
_L
P9
B_
in E

8747

U000

eth

A
pid

pho

stra

N01

ce

FSA

m
co

ain C

E1

d str

USMD

hos

dp

e--li
min
nola

smi

hei

ncor

en

r Co

iae

1,

rova

ain

er ho

ca se

ge

om

c
8,

95

ple

id p

mon

te

no

OS

sm

neu

qu

obact

nteri

lla p

00

Enter

sp. e

str

a sub

se

bsie

6_

teric

ain A

pla

aec
dii

la en

Kle

ete

pla

C1

38

SE

onel

dp

e

S
GO

Sa

te

eg

om

o
rh

o
en

t
ple

r
ch

2

om

ple

4,

017

pl

mi

o
,c

m

o
os

9
_3

,c

Lp

PC

12-

p
id

me

st

rm

er

et
pl

m

ch

t
En

me

eg

al

w

g
ei

e

m

o
en

te

ue

oso

s st

rain

om

OS

eq

M

a
str

Ce

es

ch

pl

1
E-

ae

mp

rom

las

alli

,c

ar C

sm
pla

07

id

ub

ce

co

let

4_

orv

Salm

AR

E

pM

m
as

.
sp

en

b,

,c

tii

qu

4k

str

e

pl

a
-1

er

c
ba

s
te

om

in

se

33

str

rov

pl

ete

-04

PC

a se

m

2_

ica

UK

eric

co

H1

ter

gen

ain

16

ent

PI

eq

s
ei

ce
en
qu
se

sp.

en

01

sub

1,

nc

ain

sis

rica

00

pI

M

fan

nte

pE

1_

ub

sp.

_0

la e

ng

id

e
et
pl

nel

xia

61
pE

mo

as

id

Sal

m

pla

id

sub

sp.

pl

sm

aec

hei

E1

as

ae

rm

m

in

.19

ric

ho

as

er

pl

tra

03

nte

om
,c
01
_0
15
pC

KA

5_

on

1
E6

id

as

_L

ell

act

in

xy

lat

lm

ob

t ra

in

m
as
pl

ss

bo

10

ter

as

ar

ne

_P

En

lat

ec

ge

tra

Sa

xy

ro

ad

5
C1

ae

ia

eri str

8A

in 6

etha
spho
pho

stra

orm
un

C
in
tra

bo

rc

E n te ro b

oli

rh
fre

s
ei

ar

ec

lla

m
ter far

ia c

ich

cte
er
act

ob

ad

sie

n
ai
str

cle

eb

ac
Citrob

38
200
9_0
TXM

her

a
rob
b
tro
Ci
k
ter
ac

cia

ei
ch
ae

Le

quenc
e

pC
mid
plas
038
020

Esc

te
En

ob
ter
En

ler

c
Le

rm
ho
er
ct
ba
ro
te
En

Kl

ce

n
ue

CDS

cds

cte
roba
Ente

omple
te seq
uence
17277
plasm
id p17
277A
_477,
c

e
enc

e
nc
ue

ue

nc

e

seq
te

te
se
q

mp
le

om
ple

co
3,

ano

ue

cte
ba
pl
ex
m
co
ae
ac
clo

En

ter
ac

O
RG

ob
er
En
t

ba

ter

lam

ine

tran

ras

cter

freu

ndii

t

in

i
ter

roba

cter

kobe

stra

in E

i stra

(mc

boxy

acter ho

train

ne,

r-9

lasm

16 p

E11

M

v
ero

me

as

ric

ne

de

ica

te

te
en

.

sp

b
su

e

ll
ne

llel

e

, co

tr
as

C

ad

B

i

tra

s
cae

om

pla

1, c

lete

seq

ei strain

lasmi

d pE6

1_00

lete

HER

ce

ro
cter

10 g
mcr-

09
HER

C

ii W

mp
enka

gg

er ro

act
terob

plete

1,

amed

unn
asmid

lete
comp

ain FD

seque

nce

r
tica st
y
l
o
n
i
rnith

tella o

, comp

_0

plasmid pE

1_001, com

90

rain W
ampii st

roggenk

acter
Enterob

me

mplete geno

plete seque

nce

enterica strain AR-0407 ch

smid p
065 pla

CHER0

lete seq

uence

id

-1 DNA, co
pECC18A13

. 18A13 plasm

romosome, complete geno

me

me, complete genome

Buttiauxella sp. 3AFRM03 chromoso

lete sequence

Enterobacter hormaechei strain 20710 plasmid pIMP-20710, comp

ence

, complete sequ

pOSUKPC4
PC4_L plasmid

SUK

ngensis strain O

bsp. xiangfa
r hormaechei su

Enterobacte

Enterobac

ter horma

lis strain

enterica
a subsp.

orval
serovar C

mplete
38-1, co

in C15117

plasmid p

SPRC-Ec

Salmo

nella e

nterica

2

610
train D

lasmid

-HI
pD610

p

strain S

A2009

4620 p

lasmid

pSA20

eumo
ella pn

Salm

i
Klebs

onell

a ent

nce
eque

smid
7 pla

1
GMI

Lecl

ercia

4
0187

CF
rain
rd st

o
Conc

bsie

36
R_0

o
3, c

141

Sal

mo

23

p
mid

r

1
314

in 2

tra
ca s

le
mp

, co

Sa

DR

10
505

m

ter

MP

I
C-

E
dp

om

m
ro

mi

01

p

KU

te
ac

s

om

,c

eric

D

e

om

e
om
en
eg

enc

e

let

equ

co
mp

te s

uen
ce

1335-115, complete se
CAV1335 plasmid pC
AV

4977 plasm
ltii strain 3
. steigerwa
Enterobac

ter hormae

chei subsp

cr-9 g
ed m
nnam
274 u
R9_3
_10_
_WA
TYPH
UM_
ica H
enter
ubsp.
a ente
rica s

onell

Klebsiella oxytoca strain

-263.138k
id p34977

n E5 ch
ei strai
rmaech
cter ho
Entero
ba

ospho
or ph
ene f

b, complete

plete g
me, co
m
romoso

e MC
trans
feras
ipid A
ine--l
olam
ethan

enbe
enft
ar S
sero
v
erica
subs
teric
a
Salm

nce

eque

ce

uen

seq

ete s

mpl

onel
la en

te
ple

om

1, co

Salm

1, c
_26

EM
P4-S

p. en
t

sequence

enome

CDS
plete
, com
R-9.1

ed, c
unna
m
mid
plas
004
1154
rg st
r. 36

pne
sp.
sub
iae

quence

nce
ete s
omp
l

, co
H11
id p
lasm
11 p
stra
in H
umo
niae

e st
rain
uria
asb
bac
ter
ero
Ent

seq
ete
mpl

A4
36,
id p
OX
A4
97
pla
sm
AM

Cu
ar
rov
Se
ca
eri
ent
sp.
ub
as
ric
nte

ple
te s
com

pla
50
20
00
AN
tr.
C

ac
ter
ob

eque

ple
com
id,
sm

64
13
M
DS
tra
in
be
is
ko

FS

bsie
lla p
neu
mon

e

pIM

-1A

813

nom

mid

Kle

e ge

plas

036
09-

p
mid

las

ae

Ap

ell

3-1

plet

U1

on

e
enc
equ
es

681

om

nM

3, c

strai

-21

ium

307

r
imu

0
ain

3
9-0

t str

yph

nce
eque

lete s
comp

lm

nce

63
18
pN
id
pla
sm
63
18
ter

t
ple

por

in 0
stra

New

rg

lbe

var

ar T

114,
015AV1

uence

q
mplete se

Sa

e

nc

ue

com

sero

ide
He

ica

r
ova

ser

a4,
T-8

e
nc

ue

eq
es

let

eq
es
let

mp

co

mp

EN
dp

mi

rica

r
ente
sp.

erov

id pC

ce

equen

plete s

pK29, co

e sequence
99-114, complet

plasmid pCAV10

plasmid

-1, com

9
ain NK2

pW17

plasm
1015

s
rica

CAV

ente

rain

lasmid

oniae str

En

e

2,

nN

om
en

6
EC

co

tra
i

eg

4P-

P,

es

pl

ete

et
pl

M
pI

equ
e

ch
ro
m
os
S5
ain

om

str

co

m

id

-IM

s
pla

e
ent

sub

rc
loa
ca

c
e,

ch
ei

om

3,

sm

ae

p1

52

pla

EC

H3

sp.

rica

bsp.

a su

ba
cte

nc

45

os

62

ho
rm

ue

m

id

e as

bly

, pl

asm

id:

mv

5- s

trai

n6

CN

4p

R48

las

mid

:i:-

str

ain

77

pla

se

qu

en

ce

id,

par

e

l se

enc

e

es

eq

ue

nc

e

, pa

rtia

l se

equenc

, part

om

qu

mp

eq

_0

om

EC

p
id
sm

NI

sub

ente

teric

ter
o

r
ch

ain
str

pla

EC

ca

lla

la en

ca st
oxyto

En

es

as

11
4_

ae

ae

ter

let

55

pl

gen

12

co

mp

23

smid

nce

tia

co

04

ac

ac

e
aca

ri
nte

er
ob
ac

9,

EK

clo

clo

clo

la e

one

En
t

5],

am

30

CH

ter

ter

er

nel

m
Sal

onel
Salm

siella

W17 p

a pneum

cia sp.

Klebsiell

a strain CAV1099
Klebsiella oxytoc

Phytobacter ursingii strain CAV1151 plasmid pCAV1151-296, complete sequence

Lecler

It is made available under a CC-BY-ND 4.0 International license .

Kleb

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

mo

L

Sal

e

l
ec

act
ob

a

i
rc

e
ad

ac

r
ca

ter
En

bo

rob

l
xy

te
En

sm

ac

p

4,[

nn

dp

W

6 pla

eque

sm

du

mi

90
I7

70

a

pl

ar

let

7-

ete s

rain 7

ar T

17

R4

mpl

up st

rov

str

tra

b
ro

78

a
at

ser

1,

is

in

R48

a se

las

NM

04

id

ca

R4

ko

d, co

ar.

eri

ed

be

te
En

-N

En

ent

7p

p.
rs
cte

M

ba

o
ter

eq

pl

En

cte

ter

ba
tro

r

o
rh

e
et

b

o
ter

ac

ender

riu

str

ain

Ci

p
rs

c

e
ma

ii

ue

.D

ai
str

sp.

mi

nd

-b38

imu

las

ob

as

nM

0.02

nce

plete s

CN

ub

reu

ter

e
nc

_N

ate

4p

En

T_

8
S7

i
he

ch

e,

A
84

ae

isol

ent

ov

clo

LEC

r Bra

.1, com

yph

as

rf

os

M
dp

las

ric

ain

cte

nc

E

nte

ba

e

om

S7

ter

tro

84

8

b

ro
nte

A,

m
co

ban

e
act

Ci

ue

loa

rc

sub

ac

os

C

cae

te
ple

seq

se
q

ron

id p

erova

sem

rica

ac

ue

mi

s
pla

ob

e
nc

hro
m

t
ii s

5c

ct
oba

En

c
Q,

zak

aka

er s

om

ple
te

n
rai

ete

pl

505

ae

seq

e

108

ell

n
ue

id p

s
pla

on

ce

om

Ra

lasm

nte

lm

8-M

r

la o

tel
oul

H1 p

niae

sp.

,c
om

o

in
nith

la e

equ

te s

lyti

nel

e
enc

I2

ro
Ente

s
pla

-H

o
er h
t
c
a
b

rica s

mo

te s

eg
en

i

che
mae

neu

e
equ

le
mp

f
. ho

p
subs

lla p

nce

in A

ra

ii st

nn
fma

Kle

pl
et

S

unn

d

i
enter

. ente

m

d1
ame

i
asm
l
p
5

SNI

sequ

e,
co
m

almo

nella

bsp
ca su

sp. L

ence

e
plet

, co

r
. ente

subsp

o
_1, c

2
4-00

p

erica

te s
mple

SAN

ar

lete seque

094620

niae s

erov
ica s

ho1, comp

12

ic
lla enter

Salmone

echei stra

sequence

17
pSE12-0

lasmid
-01738 p

ence

ete sequ

compl
90065,

MCR10

15_001

nce

seque

l

OS_
AARG

sp
Enterobacter

Salmonella enterica subsp.

osp
or ph

ene f

sequ

ence

e
amin
anol

ns
A tra

h

hoet

a

erob

id

--lip

n

gge

uen

feras

C
in W

a

pi
kam

Re MC

que

nce

ial se

e

quen

ce

lete
omp

,c

10.1

431 p

1, com

smid pC

ta strain E1

o

0065

omp

sph

5 ph

06
090

Ent

01, c

an
oeth

En

E61 p

C15 pla

decarboxyla

-lip
ine-

ba
itro

i str

omp

id A

sf
tran

r-1
(mc

olam

C

_00

e

RMC

eras

n
freu

cter

ds

dp
smi

B38

st
dii

te c

10.1

OZ

rain

ple

,c
172

,m
ene

0) g

p

om

oba

r
nte

s
lete

lle
.1 a

0

cr-1

e
enc

equ

a

clo

r
cte

let
omp

le, c

C
10E

IM
nP

s

e cd

s
pla

27

cl

Le

2
27-

pE

d
mi

lasm

id pC

te s

rb
eca

ia
erc

en
equ

le
mp

lat

com

e, c

ce

6c

E

.1 a

co

J65

ain

nc

g

oso

o

lm

o
en

m
hro

ae

nc

le
mp

,
me

r
nte

me

mc

a

ba

ar

a
str

eno

) ge

s
ka

nd

A
FD

C
AT

Raoul

rmaech

Leclercia a

0,

11 p

in C

lata s

E2

tr.

te g

16_0

decar

sp.

9
51

C

ple

id p

Ente

er

CR

r-9

oba

ue

act

eM

-9.1

Citr

ob

58

y
ox

seq

mp

o
,c

A

o
er

om

te

e

r
ch

Sa

ple

En

-V
IM
45
pC
id
:
m
pl
as
bl
y,
em
ss
ea
om
en

5g
C4
lat
e
iso
riu
m

ch
ma
e
or
rh
cte
ter
o

ce
en

ba

u
eq

eth

4

,c
1a
M
Elas
mi
dp

su
b
ei

er

En

s
te
ple

ter
ob

e
nc
ue
eq

act

e

es

clo

sp
.

aca

es

ste
ig

tra

in

e rw

MR

SN
17

62

alt
ii s
tra
in
M
E-

6p

1p

las

mi
d

stra
in
pP
101
64

Le
cle
rci
aa
dec
arb
oxy
lata

81

, co
0_1
p68
sm
id
pla
80
n6
stra
i
dii
ter

bac
Cit
ro

RV
IM
0

seq
u
lete
mp

5_1
p56
mid
plas
565
train
dii s
reun
ter f
bac
Citr
o

pM

e
enc

ete
mpl
, co

54_1
lasm
id p1
54 p
ain 1
ii str
eund
er fr
bact
Citr o

pla
sm
id
pP
101
642, c
om
ple
te s
equ
enc
e

sequ

, com
plete

sipne
umon
iae su
bsp. q
uasip
neum
oniae
str

sequ
e

nce

ain M

comple
te
1-HI2,
p52501
plasmid
525011
ii strain

e

enc

equ

let
mp
co

te s

enc

ple

equ

cds

te s

com

freu
n

sequenc
e

e

e

Klebs
iella q
ua

sequence

e

quenc

se q u e n c

lete se

comp

omplete

R178,

ple

com

7,
-R2
RH

A,
ph
-m
82
52
pT

ete
mpl
, co

A,

dp

Citroba
cter fre
und

pRH-

26, complete
plasmid pIMP

EC_D, c
id pOSU
-2 p la sm

lasmid

178 p

1 plasmid p
GW1, comp
lete sequenc

PC4
UVMCK

02
acae strain RJ7

train OS

coli R

me shotgun sequence
NODE_53_length_2661_cov_38.7403, whole geno

g e n sis s

clo
Enterobacter

x ia n g fa n

richia

llele

mi

DN

las

_1

is p

028

t
fan

CL

r In

4_E

a
-9.2
mcr
ne,

H1

ova
ser

NU

ca

d
mi

ence
sequ
plete
com
3-1,
-26-7
CYU

eri

id p

ge
r-9)
(mc
9.2

lasm

ent

train GZcsf-

i su b sp .

Esche

8p

RMC

L02

ase

EC

sp.

pN
smid
3 pla
-26-7
CYU

14_

sub

ce

1-1

om
,c
en

pho

sfe

Enterob

28

eq

9
_3

ge

e
let

S

rh

a
ce

e

m
no

om

2

,c

hos

rcia a

qu

es

g

p

o
,c

m

o
os

Ce

let

sm

W

o
en

e
let

m

a
str

e
ct

ce

e

m

ae

mp

pA

pC

id

m

pl

8
03

m
or

en

co

9

M

0

qu

4,

0

2
_0

02

se

02

14

Lecle

se

15

26

id

ete

81

pla

pl

HI

,c

8
03

EH

i

En

ete

e

pl

om

as

e
ch

s
te

TX

in

pl

2-

U8

id p

om

pI

om

nc

41

,c

,c

MD

pla

01

id

eq

CH

ce
en
qu
se

8A

_0

91

sm

US

in 6

e
et
pl

14

sm

stra

30

pla

AU

00

oli

45
pC

str

DU

ia c

id

-1

SM

ich

m

12

S6

10

as

pS

HV

ain

00

A0
-S

pl

id

str

arm

15
SE

5
C4

ei

rf

ain

om
,c
kb
31
_3
12

m

ch

cte

p
id

ain

las

ho

nN
strai
coli

UH

ca

sm
pla

st r

3p

ae

ba

eri

her

S1

ac

ter

H
nc
PI

ain

sfer
tran

ae N

A
pid

oac

. cl

bsp

e su

e--li
min
nola

aca

clo

eri

28

ei

ch

str

rm

tro

Esc

M
pI

Ci

id

ch

ei

las
2p
28
T5

10

ae

ae

ob

in

A0
5-S

rm

m
as
pl

rm

ter

tra

1
in
tra

ho

19

ho

En

es

as
ric
nte
.e

ter

3.
_0
L5
9_
_P

ter

ia
erich
Esch

etha
spho
pho

ter

ent

aca
clo

sp

ac

ob

EB

ac

r sakazakii s

rmaeche

38
200
9_0
TXM

bac

lla

er

ub

er

n
ai
str

ob

Klebsiella aerogenes strain KA
_P10_L5_03.19 plasmid pIMPIn
cH12_334kb, complete sequen
ce

a c te r h o

pC
mid
plas
038
020

ero

Ent
one

act
ob
ter
En

s
ica
ter
en
lla
ne
t
En

ei
ch
ae

ter

Cronobacte

ain

E n te ro b

tr
sis s
gen
gfan
xian
bsp.
i su
eche
rma
r ho

m
Sal

o
lm
Sa

rm
ho
er
ct
ba
ro
te
En
En

ce

n
ue

CDS

cte
roba
Ente
ain

tr
sis s
gen
gfan
xian
bsp.
i su
eche
rma
r ho

ce

plete
se

sequ
en
com
plete

enc

e

4- 2,

enc

e

sequ

IM
4
-V
pC
45

co
mp
let

ce
en
qu
om

pl
ete

sse
mb
ly

,c

me
a

02

ge

00

no

38

mi
17
62
6p
las

9_
CT
XM

te
C4
5

m

ter
ium

id
p

iso
la

MR
SN

las
EH
0

om
ple

20

xb

03

ac

8p

in
tra
es
clo
aca

CH
str
ain

rc

ei

cte

e

rm

ter
o

ae

ba

ch

nc

loa

ca

W

ec

er

ue

ob
act

eq

En
ter

se

,p

M0
81
3,
dp
MR
VI

stra
in
680
pla
sm
id
p68
0_1
,

Cit
rob
act
er
fre
und
ii

es

com
ple
te s
equ
enc
e

p56
sm
id
pla
65
n5
stra
i
dii
freu
n
ter

bac
Cit
ro

eq
ue
nc
e

seq
u
lete
mp
5_1

, co

p15
mid
plas
154
train
dii s
reun
ter f
bac
Citr
o

las
mi
d:

ete
mpl
, co
4_1

164
pP10
ylata
r box
deca
cia a
Lecl
er

NODE_

Klebs
iella p
ne

ome

uence

uence

te seq

60_leng

umon
ia

th_2517

strai
n

_cov_5

e sub
sp. pn
eumo
nia

1.84, w

e stra

plasm
id pP
1016

in H1
1

hole ge
nome s

plasm
id

hotgun

pH11
, com

sequenc
e

genome
e, complete
chromosom
DSM 13645
r kobei strain

omple

complete sequence

te sequence
1491, comple

1-1, c

p le te se q
264, com

U814

en
lete g

cds

ds

e

s
te

enc

le
mp

equ

co

te s

1,

te c

ple

ple

com

om

kb,

e, c

331

llel

ete
mpl
, co

.1 a

llele

cr-9

e, m

12_
cH
PIn
IM

Enterobacte

pSHV12-130

I2 -1 5 0 2
id p In c H
6 p la sm

MP, complete sequence

i stra in S

USMD

gen

dp

p
com
E20,

r-9)

a
-9.2
mcr
ne,

mc

r sp.
bacte

.1 (

mi

Enterobacter cloacae plasmid pE
C-I

in S13 plasmid
rmaechei stra

rmaeche

id pA

ro
Ente

R-9

MC

ge
r-9)
(mc
9.2

ase

sfer

RMC

tran

ase

plasm

ine

5_001,
Enterobacter hormaechei strain C45 plasmid pC4

ho
Enterobacter

a c te r h o

08141

lam

las

a
ov

UK

12-

ca

ter

En

ho

p
bs

a
ric

ac
ob
er
En
t

n
ae

e

su

om

t
yla

rb
eca

plas

mid

C

1, co

mple

IM
nP

st

ae
oac

amed

nce

2,

i
lasm

p

38

B
rain

equ

is
ndi

enc

e

osp

ph
065

090

ER
CH

feras

W

rain

i st
mpi

10
mcr-

0065

09
HER

ce

f

gene

, comp

te se
omple

ed1, c

am
d unn
i
m
s
a
l

p

OS
AARG

D

rain F

ica st
inolyt

ornith

tella
Raoul

mplet
0065, co

9

id pM
65 plasm

900

rain W
ampii st

roggenk

acter
Enterob

enome

, complete g

complete s

equence

13-1 DNA
id pECC18A

sm

sp. 18A13 pla

Enterobacter

V1015 plasmid pCAV1015

-114, complete sequence

me, complete genome

Buttiauxella sp. 3AFRM03 chromoso

complete genome

Salmonella enterica subsp. enterica serovar Newport strain 0307-213,

mplete sequence

rica

rica subsp. ente

Salmonella ente

Klebsiella

C
e strain E

Lecler

train CAV

cia ade

te
erobac

Ent

Lecle

rcia s

p. LS

ome

NIH1

gen
plete

o

Esch

I790

. NM
ter sp

erich

osom

Kle

m
chro

5
in S

bsie

ra
ei st

aech

nce

-1,

7
W1

17

e
te s

p
com

tero

dp
smi

pla

ple

m
, co

En

ter

I2

-H
863

id p

t
ple

in N

e

nt

d
mi

qu
en
c
se
ete

ce
en
eq
u
mp

eq
ue
nc

e

let
es
co

e
uen
c

subsp. ente
a enterica
Salmonell

ence
pGW1, complete sequ
strain GZcsf-1 plasmid
Cronobacter sakazakii

artial sequ
en
plasmid, p
p strain 76
rica serova
r Braenderu

urium
Typhim
serovar
terica s
ella en
Salmon

ce

ubsp. e

nterica

a ente
rica s
ubsp.

uen
seq

pid A

ine--li

anolam

ence

lete sequ

phoeth

r phos

ene fo

cr-9 g

onell

e

lete

med m

ed, comp

id unnam

Salm

ce

ence
ial sequ
4 plasm
id, part
strain 6
var. 5-

12:i:4,[5],
ica se
rovar
enter

roba

cter

cloa

ter

cae

freu

ndii

strai
n 17
4 pla

strain

smid

77 pl

unna

asmid

med

, part

1, co

mpl

ial se

ete s

quen

ce

eque

ete
omp
l
R47
-30
9, c
id p
lasm
47 p
stra
in R

010
n1
5-S
A
stra
i
eric
a
ent
sub
sp.

nce

seq
uen

ce

seq
mp
010
2
-SA

id p
SE
15
28
pla
sm

mo
neu
la p
rica

Ente

enc

equ
es

mp

, co

ent
e

let
mp

M1

lla

co
b,
8k

SE
P4-

pIM

one

.13
63

mid

4 unna

004 plasm

Sal
m

ce

7-2
97

Kl

n
ue

34
dp

s
pla

nce

que

e se

R48

: CN

nome
te ge

9_327

_10_R

mid

plas

mple

plet

bly,

com

sem

-3,

U1
nM

141

trai

p23

e as
enom

s
um

ob

seq

mi

ri
mu

mid

ac
ter
ho
rm

nia

ae

es

ch

tra
i

ei
s

nN

tra
in

K2

20

9p

71

las

mi

8, c
o

dp

mi

K2

dp

9,

IM

lete

P-

com

20

ple

71

0,

te s

co

equ

mp

enc

let

e

es

.1,
20
46
09
SA
20
dp
mi
las
0p
62
94

00
SA
2
in
tra
as
ric
nte
ell
ae
lm
on

te

ple

om

phi

plas

48 g

e, co

H_WA

. 361154

quence
NA, complete se

14_ECL028_1 D

8 plasmid pNUH

str
ftenberg

Citr
oba
c

_D
EC
SU
pO
id
m
pl
as
42
PC

CK
M
UV
OS
ain

ce

en

qu
e
nc

ue

eq

c
6,

las
7p
97
34

Ty

41

CNR

Sa

se

str

es

eq

ue

nc

ete

ete
es

ge
ns
is

es

pl

pl
let

an
gf
an

let

pM

om

m
mp
co

xi

co

4,

-29

1
15

p.

mp

mp

m

,c

8a

1
AV
pC

su
bs

co

co

4A

TEN
dp

id

in

ch
ei

com

e

p1

88

mi

sm

pla

a
str

r
ova

231

ae

1,

enc

let

3,

id

ce

equ

pla

S7

,
PQ

s
pla

1
15

ii
alt

rw

ige

ser

rain

late

ho
rm

IM
C-

H3

V1
CA

ste

rica

a st
ytic

e iso

ter

pE

NI

ain

sp.
sub

nte
p. e

nol

onia
eum

osom

_TYP

rovar Sen

a HUM

hrom
E5 c

er
ob
ac

ho

2-m

52

id

m

EC

str

hei

aec

ubs

ithi

a pn

train

enteric

se
enterica

En
t

as

ae

ii
ng

rm
ho

s
ca

orn

siell

s
chei

subsp.

a subsp.
a enteric

nterica

e
orma

nella e

ter h
robac

Salmo

ll
Salmone

e NUH14_ECL02
cae subsp. cloaca

Citrobacter freundii strain 525011 plasmid p525011-HI2, complete sequence

Enterobacter cloa

It is made available under a CC-BY-ND 4.0 International license .

Ente

e

Kl

lla

ch

Es

ie
bs

ri
nte

i
er

qu

Kleb

lla

ch

ulte

i
as

ia

la e

pn

co

Rao

m
eu

nel
mo

li

a
str

er

in

i
on

rsi
ru

CY

N

Sal

ae

b
su

U

act
ob

s

p.

-2

a
qu

cte

3

7
6-

sip

al

ba

ne

ter
En

n
mo

a
pl

seq

te s

45

as

lete

ple

T5

_0

pl

mp

mp

dp

88

pl

sm

o

um

Ec

2p

id

4A

, co

pS

C-

S7

ac
clo

a
ni

ter

t
en

id

pN

c
ba

es

yto
Ph

i
tra

c
eri

,c
om
pl

U

CY

P26

PR

M

ae

1

nM

id

sm

ac

6
-2

pla

A,

str

lo

7
72

id p

ph

23

ain

115

sm

55

ei

nce

uen

17

str

ch

ro

t
en

-7

C1

04

rc

1
3-

pla

28

ae

te
En

7p

as

S

,c

sm

la

c
eri

a
ell

om

ain

W

rm

te
ac

e
aS

p

RJ7

EK

ob

id

p1

t
le

V13

, co

mi

ho

ce

eque

35-

rain

CH

er

a
rov

p.

es

7

7
72

rC

s
ub

u
eq

4
A_

t
En

n

ter

quence

equen

ete s

sm

T5

lete se

lete s

mpl

id p

str

tra

ac

comp

IM

las

in

8, co

, comp

asm

aec

is

ob

e

t
as

be

en

77

ae

R17

5 pl

rm

ko

ter

ce

,c

r. C

mo

medRxiv preprint doi: https://doi.org/10.1101/2019.12.24.19015784; this version posted December 30, 2019. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

om

FS

a
ub

133

28

En

let

p

AN

r
nte

ter

q

e
es

ho

ac

ue

iel

00

ae

l
Sa

s
pla

20

.e

ica

50

e
nc

er

ain

ob

0p
las

r
nte

su

AV

RH-

, complete

4-NDM

38d,

e st

ac

ter

ebs

ero

s
ica

in C

51

clo

En

m

o
,c

ter

seq

ter

r
va

a
Inf

t
ple

aca

ac

n
ue

sm

nte

ob

ce

pR

id

la
is p

stra

p70780

EC-b

id p

1099-114

CA

clo

hei

ter

,c

R
H-

er c

En

om

27

tra
es

ca
loa

act

ue

En

186

ll
ne

oca

mid pCAV

id pL

lasm

02

ob

e
nc

eq
es

m
las

3p

bsp

ter

u

N1

t

bac

e
enc

eq
te s

ia s

Lec

plasm

78 p

En

p. W

lerc

E

xyt

le

Ent

ac
rob

lla o

que

horm

er

li R1

n
e ge
t
e
l
p

m
e, co

act
erob

ia co

ome

ac

b
Citro

lasmid

com
ome,

mos

chr
4_11

ylata p

chrom

KU_
r sp. D

1099 plas

carbox

osome

1
NT_0

rase M

transfe
1, com

CR-9.
DS

plete C

0.02

oxytoca s

sequence

complete

EC62,
pIMP-4-

id
62 plasm

ca

cter cloa

Enteroba

13-1A_261, co
smid p09-0368

la

9-036813-1A p

berg strain 0
serovar Heidel

se

qu

en

ce

nce

e seque

CHER0

lete seq

uence

e

quenc

c

seque

nce

h

osp
or ph

gg
ter ro

roba

ns
A tra

C

mp
enka

quen

e
amin
anol

hoet

t

bac

ero
Ent

id

--lip

a

enk

gg
er ro

Re MC

e

eq

ue

nc

e

lete

seq

uen

ce

sequence

lete
omp

,c

10.1

CR10_0

8-MDR

Klebsiella oxytoca strain CA

th
hoe

_431

plete

A tr

ine

rob

HI2

era
ansf

id
--lip

lam
ano

freu

r
acte

1
CR-

se M

dp

o

r
nte

17
OZ

r-1
(mc

0.1

p
com

mc
ne,

e

0) g

ue
seq

lete

ii W

te se

1, com

pOXA436,

r-10

l

rc

te
bac

lle
.1 a

ete
mpl

o

le, c

rai

Ente

d unn

10E

s
pla

t

te s

pD6

E
dp

B

cle

Le

7

C2

ad

a
rci

2
27-

mi

Cit

610

, co

ox

com

ple

te s

t

as

l

en
equ

le
mp

J65

n
rai

E

1, c

ce

ro

e

38-

o

mo

h
6c

n
mo

me

g

le
mp

,c

e
som

ell

nc

o
en

te

.e

c
de

enc

017

me

r
se

ri
nte

equ

002_

p50510

497 plasmid

9p

train AMA

ce
en

r asburiae s

rM

F

in D

pGM

lasmi

plasmid

00

Enterobacte

05108

1_

mid

365 p

strain 5

sfer
tran

ano

3.1

kazakii

ri

ea

n
ba

str

te
ne

s
ka

da

A
DA

10-

plas

AR_0

u
eq

acter sa

strain

E1

annii

s
te
ple

Cronob

hoffm

dp
mi
las

ubsp.

1p

chei s

ain

C
AT

tr.

R

o

51

C

te s

stra

I14-

rmae

U000

eth

5_0
_L
P9
B_
in E

8747

A
pid

pho

stra

N01

ce

FSA

m
co

ain C

E1

d str

USMD

hos

dp

e--li
min
nola

smi

hei

ncor

en

r Co

iae

1,

rova

ain

er ho

ca se

ge

om

c
8,

95

ple

id p

mon

te

no

OS

sm

neu

qu

obact

nteri

lla p

00

Enter

sp. e

str

a sub

se

bsie

6_

teric

ain A

pla

aec
dii

la en

Kle

ete

pla

C1

38

SE

onel

dp

e

S
GO

Sa

te

eg

om

o
rh

o
en

t
ple

r
ch

2

om

ple

4,

017

pl

mi

o
,c

m

o
os

9
_3

,c

Lp

PC

12-

p
id

me

st

rm

er

et
pl

m

ch

t
En

me

eg

al

w

g
ei

e

m

o
en

te

ue

oso

s st

rain

om

OS

eq

M

a
str

Ce

es

ch

pl

1
E-

ae

mp

rom

las

alli

,c

ar C

sm
pla

07

id

ub

ce

co

let

4_

orv

Salm

AR

E

pM

m
as

.
sp

en

b,

,c

tii

qu

4k

str

e

pl

a
-1

er

c
ba

s
te

om

in

se

33

str

rov

pl

ete

-04

PC

a se

m

2_

ica

UK

eric

co

H1

ter

gen

ain

16

ent

PI

eq

s
ei

ce
en
qu
se

sp.

en

01

sub

1,

nc

ain

sis

rica

00

pI

M

fan

nte

pE

1_

ub

sp.

_0

la e

ng

id

e
et
pl

nel

xia

61
pE

mo

as

id

Sal

m

pla

id

sub

sp.

pl

sm

aec

hei

E1

as

ae

rm

m

in

.19

ric

ho

as

er

pl

tra

03

nte

om
,c
01
_0
15
pC

KA

5_

on

1
E6

id

as

_L

ell

act

in

xy

lat

lm

ob

t ra

in

m
as
pl

ss

bo

10

ter

as

ar

ne

_P

En

lat

ec

ge

tra

Sa

xy

ro

ad

5
C1

ae

ia

eri str

8A

in 6

etha
spho
pho

stra

orm
un

C
in
tra

bo

rc

E n te ro b

oli

rh
fre

s
ei

ar

ec

lla

m
ter far

ia c

ich

cte
er
act

ob

ad

sie

n
ai
str

cle

eb

ac
Citrob

38
200
9_0
TXM

her

a
rob
b
tro
Ci
k
ter
ac

cia

ei
ch
ae

Le

quenc
e

pC
mid
plas
038
020

Esc

te
En

ob
ter
En

ler

c
Le

rm
ho
er
ct
ba
ro
te
En

Kl

ce

n
ue

CDS

cds

